| Risk of endocrine complications in cancer patients treated with immune check point inhibitors: a meta-analysis O Abdel-Rahman, H ElHalawani, M Fouad Future Oncology 12 (3), 413-425, 2016 | 153 | 2016 |
| Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis O Abdel-Rahman, M Fouad Therapeutic advances in respiratory disease 10 (3), 183-193, 2016 | 129 | 2016 |
| Risk of gastrointestinal complications in cancer patients treated with immune checkpoint inhibitors: a meta-analysis O Abdel-Rahman, H ElHalawani, M Fouad Immunotherapy 7 (11), 1213-1227, 2015 | 87 | 2015 |
| Risk of cutaneous toxicities in patients with solid tumors treated with immune checkpoint inhibitors: a meta-analysis O Abdel-Rahman, H ElHalawani, M Fouad Future oncology 11 (17), 2471-2484, 2015 | 84 | 2015 |
| Sorafenib-based combination as a first line treatment for advanced hepatocellular carcinoma: a systematic review of the literature O Abdel-Rahman, M Fouad Critical reviews in oncology/hematology 91 (1), 1-8, 2014 | 80 | 2014 |
| Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib, axitinib, cediranib or regorafenib: an updated systematic review and comparative meta … O Abdel-Rahman, M Fouad Critical reviews in oncology/hematology 92 (3), 194-207, 2014 | 70 | 2014 |
| Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab: a systematic review and meta-analysis O Abdel-Rahman, M Fouad Critical Reviews in Oncology/Hematology 93 (2), 127-135, 2015 | 67 | 2015 |
| Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: a meta-analysis O Abdel-Rahman, H ElHalawani, M Fouad Expert opinion on drug safety 14 (10), 1507-1518, 2015 | 56 | 2015 |
| A network meta-analysis of the risk of immune-related renal toxicity in cancer patients treated with immune checkpoint inhibitors O Abdel-Rahman, M Fouad Immunotherapy 8 (5), 665-674, 2016 | 52 | 2016 |
| Role of antioxidants in gestational diabetes mellitus and relation to fetal outcome: a randomized controlled trial AM Maged, H Torky, MA Fouad, SH GadAllah, NM Waked, AS Gayed, ... The Journal of Maternal-Fetal & Neonatal Medicine 29 (24), 4049-4054, 2016 | 47 | 2016 |
| Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis O Abdel-Rahman, M Fouad Expert review of anticancer therapy 14 (9), 1063-1073, 2014 | 43 | 2014 |
| Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature O Abdel-Rahman, M Fouad Journal of cancer research and clinical oncology 141, 295-305, 2015 | 42 | 2015 |
| Temozolomide-based combination for advanced neuroendocrine neoplasms: a systematic review of the literature O Abdel-Rahman, M Fouad Future oncology 11 (8), 1275-1290, 2015 | 33 | 2015 |
| Risk of cardiovascular toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis O Abdel-Rahman, M Fouad Future Oncology 10 (12), 1981-1992, 2014 | 30 | 2014 |
| Added value of contrast-enhanced mammography in assessment of breast asymmetries R Wessam, MMM Gomaa, MA Fouad, SM Mokhtar, YM Tohamey The British journal of radiology 92 (1098), 20180245, 2019 | 27 | 2019 |
| The epidemiology of schistosomiasis in Egypt: Ismailia governorate. ZM Nooman, AH Hasan, Y Waheeb, AM Mishriky, M Ragheb, AN Abu-Saif, ... The American journal of tropical medicine and hygiene 62 (2_suppl), 35-41, 2000 | 24 | 2000 |
| Third-trimester uterine artery Doppler measurement and maternal postpartum outcome among patients with severe pre-eclampsia AM Maged, N ElNassery, M Fouad, A Abdelhafiz, W Al Mostafa International Journal of Gynecology & Obstetrics 131 (1), 49-53, 2015 | 23 | 2015 |
| The use and limitations of ultrasonography in the diagnosis of liver morbidity attributable to Schistosoma mansoni infection in community-based surveys ZM Nooman, AH Hassan, AM Mishirirky, M Ragheb, AN Abu-Saif, ... MEMORIAS-INSTITUTO OSWALDO CRUZ 90, 147-154, 1995 | 23 | 1995 |
| Risk of mucocutaneous toxicities in patients with solid tumors treated with sunitinib: a critical review and meta analysis. FM Abdel-Rahman O | 23* | |
| Efficacy and toxicity of sunitinib for non clear cell renal cell carcinoma (RCC): a systematic review of the literature O Abdel-Rahman, M Fouad Critical Reviews in Oncology/Hematology 94 (2), 238-250, 2015 | 22 | 2015 |
